GlassScriptPhysician profile
Sidharth G Sharma
NPI 1396069050
$7,421.35
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,792 · 2020: $2,294 · 2021: $336.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $1,609.02 | 2019-2021 | |
| Allergan, INC. | $1,265.96 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $731.18 | 2019-2021 | |
| Neurocrine Biosciences, INC. | $559.57 | 2019-2021 | |
| Alkermes, INC. | $426.98 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $387.26 | 2019-2021 | |
| Ironshore Pharmaceuticals INC. | $371.42 | 2019-2020 | |
| Lundbeck LLC | $346.05 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $327.65 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $225.75 | 2019-2021 | |
| Shire North American Group INC | $195.22 | 2019 | |
| Vanda Pharmaceuticals INC. | $188.78 | 2019 | |
| Jazz Pharmaceuticals INC. | $148.21 | 2019-2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $127.86 | 2020 | |
| Neos Therapeutics, LP | $121.14 | 2019-2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $113.03 | 2021 | |
| Eisai INC. | $92.06 | 2020-2021 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $74.05 | 2020 | |
| Brainsway USA INC | $32.00 | 2019 | |
| Arbor Pharmaceuticals, INC. | $30.98 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $29.54 | 2019 | |
| Merck Sharp & Dohme LLC | $17.64 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sidharth Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.